Launch of the SphenoCath®, 2015

Launch of the SphenoCath® intranasal catheter in Switzerland
July 1, 2015

Parimed broadens its portfolio in the Swiss market and introduce a new patented intranasal catheter SphenoCath®. The device allows a simple and effective procedure for achieving neuromodulation of the sphenopalatine complex in headache patients.

The revolutionary SphenoCath® device effectively delivers anesthetics through the nasal cavity, achieving a sphenopalatine ganglion block for migraine pain without the use of needles or cotton swabs. The treatment works for all types of migraines and for most types of headache pain, from cluster headaches to trigeminal neuralgia to atypical facial pain and more, with long-lasting relief.

The SphenoCath®procedure is both low risk and effective in patients of all ages (adults and children), as well as pregnant women.